AD pathogenesis arises from dynamic interactions between amyloid-β (Aβ) plaques, tau pathology, and microglial dysfunction, with microglia exhibiting stage-specific roles in disease progression (Figure 3A). This evidence concerns the gene MAPT and Alzheimer disease.